SmartNuclide
Suzhou
About SmartNuclide
SmartNuclide is dedicated to the discovery, manufacture, and marketing of nuclear medicine diagnostic and therapeutic pharmaceuticals. The company established a number of research and development pathways for radiopharmaceutical medications, including recombinant proteins, imaging, and radiotherapeutic pharmaceuticals.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $18.7M
- Funding stage: Late Stage Venture
- Last round: Series C (Apr 2024)
- Website: smartnucl.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/smartnuclide-151665 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.